Yashooa Raya Kh, Duranti Elisa, Conconi Donatella, Lavitrano Marialuisa, Mustafa Suhad A, Villa Chiara
Department of Biology, College of Education for Pure Science, University of Al-Hamdaniya, Mosul 41002, Iraq.
School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
Int J Mol Sci. 2025 Jan 13;26(2):626. doi: 10.3390/ijms26020626.
MicroRNAs (miRNAs) are a class of small non-coding RNAs (ncRNAs) crucial for regulating gene expression at the post-transcriptional level. Recent evidence has shown that miRNAs are also found in mitochondria, organelles that produce energy in the cell. These mitochondrial miRNAs, also known as mitomiRs, are essential for regulating mitochondrial function and metabolism. MitomiRs can originate from the nucleus, following traditional miRNA biogenesis pathways, or potentially from mitochondrial DNA, allowing them to directly affect gene expression and cellular energy dynamics within the mitochondrion. While miRNAs have been extensively investigated, the function and involvement of mitomiRs in the development of neurodegenerative disorders like Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis remain to be elucidated. This review aims to discuss findings on the role of mitomiRs in such diseases and their potential as therapeutic targets, as well as to highlight future research directions.
微小RNA(miRNA)是一类小的非编码RNA(ncRNA),对转录后水平的基因表达调控至关重要。最近的证据表明,在细胞中产生能量的细胞器线粒体中也发现了miRNA。这些线粒体miRNA,也称为线粒体微小RNA(mitomiR),对于调节线粒体功能和代谢至关重要。MitomiR可以遵循传统的miRNA生物发生途径源自细胞核,也可能源自线粒体DNA,从而使它们能够直接影响线粒体内的基因表达和细胞能量动态。虽然miRNA已被广泛研究,但线粒体微小RNA在阿尔茨海默病、帕金森病和肌萎缩侧索硬化等神经退行性疾病发展中的功能和作用仍有待阐明。本综述旨在讨论线粒体微小RNA在这些疾病中的作用及其作为治疗靶点的潜力的研究结果,并突出未来的研究方向。